1 in 8 women will be diagnosed with breast cancer. Current treatments for a specific subtype of breast cancer (HER2+), is not sufficient, as patients often experience cancer recurrence. The goal of this project is to direct a patient's own body to "re-direct" these cancer cells to behave more like normal cells -- potentially providing an alternate form of treatment while making the cancer cells more susceptible to current treatments.